Fighting Medical Misinformation Is Our Lane Now
“Total burnout,” said one colleague of mine while stepping out of a patient’s room, moments after being…
Vaccine
-
Fighting Medical Misinformation Is Our Lane Now
“Total burnout,” said one colleague of mine while stepping out of a patient’s room, moments after being... -
How the COVID-19 mRNA Vaccines Work, and Some Current Concerns
Two COVID-19 vaccine candidates, one from Pfizer-BioNTech and the other from Moderna, have received emergency use authorization... -
Frequent ED Users Often Need Extra Help Accessing Health Resources
Recently, one of our frequent emergency department users, an older woman with alabaster skin who I had...
How the COVID-19 mRNA Vaccines Work, and Some Current Concerns
Two COVID-19 vaccine candidates, one from Pfizer-BioNTech and the other from Moderna, have received emergency use authorization…
Frequent ED Users Often Need Extra Help Accessing Health Resources
Recently, one of our frequent emergency department users, an older woman with alabaster skin who I had…
Frequent Emergency Department User Stats and Resources
Editor’s Note: Read Dr. Cedric Dark’s commentary on this EMRA + PolicyRx Health Policy Journal Club article….
First-in-human Study Has Good News for Universal Flu Vaccine
Researchers may be one step closer to creating a universal influenza vaccine after successfully testing a new…
Overview of COVID-19 Vaccine Research
With thousands of articles published weekly on COVID-19, navigating the literature on this emerging infectious disease can…
Takeda’s Zika Vaccine Gets U.S. FDA’s ‘Fast Track’ Status
Japan’s Takeda Pharmaceutical Co Ltd said on Monday the U.S. Food and Drug Administration (FDA) had granted…
Vaccination May be Curbing Emergency Department Visits for Shingles
Emergency department (ED) visits for shingles fell in the past decade for people aged 60 and older…
WHO Issues Yellow Fever Warning as Deadly Outbreak Grows
Amid rising concern over a deadly outbreak of yellow fever spreading from Angola, the World Health Organization…
Johnson & Johnson Begins Ebola Vaccine Trials in Sierra Leone
Johnson & Johnson (J&J) has begun a clinical trial of a two-shot Ebola vaccine in Sierra Leone,…